Skip to content

Clinical trials

Enrolling by invitation Observational Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Observational Status: Enrolling by invitation Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20033
20041
20091
20111
20141
20182
20191
20202
20215
20222
20232
20245
20257
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
The Wellcome Sanger Institute3
China-Japan Friendship Hospital2
National Heart, Lung, and Blood Institute (NHLBI)2
Assistance Publique - Hôpitaux de Paris1
Audubon Bioscience1
Certis Oncology Solutions, Inc1
Chinese PLA General Hospital1
Duke University1
IRCCS Azienda Ospedaliero-Universitaria di Bologna1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms40
Diabetes Mellitus4
Breast Neoplasms3
Cardiovascular Diseases3
Asthma2
Atrial Fibrillation2
Cerebrovascular Disorders2
Communicable Diseases2
Head and Neck Neoplasms2
Hematologic Neoplasms2

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.